MarketBeat Instant News Alerts 2 hours agoSentinelOne (NYSE:S) Price Target Raised to $31.00MarketBeatNeedham & Company LLC increased their target price on SentinelOne from $26.00 to $31.00 and gave the company a "buy" rating in a report on Tuesday.NYSE:SRead SentinelOne (NYSE:S) Price Target Raised to $31.002 hours agoBetter Home & Finance (NASDAQ:BETR) Stock Gets Price Target Reduction from Needham & Company LLCMarketBeatNeedham & Company LLC dropped their price target on Better Home & Finance from $25.00 to $15.00 and set a "buy" rating on the stock in a research note on Tuesday.NASDAQ:BETRRead Better Home & Finance (NASDAQ:BETR) Stock Gets Price Target Reduction from Needham & Company LLC2 hours agoNeedham & Company LLC Issues Pessimistic Forecast for Equifax (NYSE:EFX) Stock PriceMarketBeatNeedham & Company LLC reduced their price objective on Equifax from $245.00 to $190.00 and set a "buy" rating for the company in a research note on Tuesday.NYSE:EFXRead Needham & Company LLC Issues Pessimistic Forecast for Equifax (NYSE:EFX) Stock Price2 hours agoFair Isaac (NYSE:FICO) Given New $1,100.00 Price Target at Needham & Company LLCMarketBeatNeedham & Company LLC reduced their target price on Fair Isaac from $1,650.00 to $1,100.00 and set a "buy" rating on the stock in a research report on Tuesday.NYSE:FICORead Fair Isaac (NYSE:FICO) Given New $1,100.00 Price Target at Needham & Company LLC2 hours agoTransUnion (NYSE:TRU) Stock Gets Price Target Trim from Needham & Company LLCMarketBeatNeedham & Company LLC cut their target price on shares of TransUnion from $100.00 to $85.00 and set a "buy" rating for the company in a research note on Tuesday.NYSE:TRURead TransUnion (NYSE:TRU) Stock Gets Price Target Trim from Needham & Company LLC2 hours agoNurix Therapeutics' (NRIX) Buy Rating Reiterated at Needham & Company LLCMarketBeatNeedham & Company LLC reaffirmed a "buy" rating and issued a $34.00 target price on shares of Nurix Therapeutics in a report on Tuesday.NASDAQ:NRIXRead Nurix Therapeutics' (NRIX) Buy Rating Reiterated at Needham & Company LLC Trending News1223,354 Shares in USA Rare Earth Inc. $USAR Purchased by Overbrook Management Corp2Stock Traders Purchase High Volume of Almonty Industries Call Options (NASDAQ:ALM)3IREN (NASDAQ:IREN) Stock Falls 7.7% - Should You Sell?4GameStop (NYSE:GME) Stock Sees Heavy Call Option Buying5AST SpaceMobile (NASDAQ:ASTS) Shares Gap Down - Should You Sell?6Eos Energy Enterprises (NASDAQ:EOSE) Stock Price Down 5.6% - Here's What Happened7Amazon.com (NASDAQ:AMZN) Stock Price Up 3.3% - Here's Why8Fermi (NASDAQ:FRMI) Reaches New 52-Week Low - Should You Sell? All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords More filters Fewer filters Done 2 hours agoRexford Industrial Realty (NYSE:REXR) Stock Lifted to "Outperform" by MizuhoMarketBeatNYSE:REXRRead Rexford Industrial Realty (NYSE:REXR) Stock Lifted to "Outperform" by Mizuho2 hours agoMongoDB's (MDB) Buy Rating Reiterated at Needham & Company LLCMarketBeatNASDAQ:MDBRead MongoDB's (MDB) Buy Rating Reiterated at Needham & Company LLC2 hours agoZenas BioPharma (NASDAQ:ZBIO) Stock Rating Reaffirmed as Buy by HC WainwrightMarketBeatNASDAQ:ZBIORead Zenas BioPharma (NASDAQ:ZBIO) Stock Rating Reaffirmed as Buy by HC Wainwright2 hours agoIncyte's (INCY) Buy Rating Reaffirmed at HC WainwrightMarketBeatNASDAQ:INCYRead Incyte's (INCY) Buy Rating Reaffirmed at HC Wainwright2 hours agoHarmony Biosciences (NASDAQ:HRMY) Given "Buy" Rating at HC WainwrightMarketBeatNASDAQ:HRMYRead Harmony Biosciences (NASDAQ:HRMY) Given "Buy" Rating at HC Wainwright2 hours agoPalisade Bio (NASDAQ:PALI) Stock Keeps "Buy" Rating at HC WainwrightMarketBeatNASDAQ:PALIRead Palisade Bio (NASDAQ:PALI) Stock Keeps "Buy" Rating at HC Wainwright2 hours agoSyndax Pharmaceuticals (NASDAQ:SNDX) Given Buy Rating at HC WainwrightMarketBeatNASDAQ:SNDXRead Syndax Pharmaceuticals (NASDAQ:SNDX) Given Buy Rating at HC Wainwright2 hours agoThe Goldman Sachs Group Has Lowered Expectations for Fidelity National Information Services (NYSE:FIS) Stock PriceMarketBeatNYSE:FISRead The Goldman Sachs Group Has Lowered Expectations for Fidelity National Information Services (NYSE:FIS) Stock Price2 hours agoAffirm (NASDAQ:AFRM) Stock Price Target Cut by The Goldman Sachs GroupMarketBeatNASDAQ:AFRMRead Affirm (NASDAQ:AFRM) Stock Price Target Cut by The Goldman Sachs Group2 hours agoNCR Voyix (NYSE:VYX) Stock Gets Price Target Cut from The Goldman Sachs GroupMarketBeatNYSE:VYXRead NCR Voyix (NYSE:VYX) Stock Gets Price Target Cut from The Goldman Sachs Group2 hours agoDomino's Pizza's (DPZ) Hold Rating Reiterated at TD CowenMarketBeatNASDAQ:DPZRead Domino's Pizza's (DPZ) Hold Rating Reiterated at TD Cowen2 hours agoUpstart (NASDAQ:UPST) Price Target Cut to $28.00 by Analysts at The Goldman Sachs GroupMarketBeatNASDAQ:UPSTRead Upstart (NASDAQ:UPST) Price Target Cut to $28.00 by Analysts at The Goldman Sachs Group2 hours agoNurix Therapeutics (NASDAQ:NRIX) Stock Price Expected to Rise, Robert W. Baird Analyst SaysMarketBeatNASDAQ:NRIXRead Nurix Therapeutics (NASDAQ:NRIX) Stock Price Expected to Rise, Robert W. Baird Analyst Says2 hours agoCarlisle Companies (NYSE:CSL) Stock Price Target Cut by Robert W. BairdMarketBeatNYSE:CSLRead Carlisle Companies (NYSE:CSL) Stock Price Target Cut by Robert W. Baird2 hours agoRobert W. Baird Issues Pessimistic Forecast for James Hardie Industries (NYSE:JHX) Stock PriceMarketBeatNYSE:JHXRead Robert W. Baird Issues Pessimistic Forecast for James Hardie Industries (NYSE:JHX) Stock Price2 hours agoPershing Square's (PS) "Underperform" Rating Reaffirmed at Bank of AmericaMarketBeatNYSE:PSRead Pershing Square's (PS) "Underperform" Rating Reaffirmed at Bank of America2 hours agoCenterPoint Energy (NYSE:CNP) Price Target Cut to $44.00 by Analysts at KeyCorpMarketBeatNYSE:CNPRead CenterPoint Energy (NYSE:CNP) Price Target Cut to $44.00 by Analysts at KeyCorp2 hours agoHyatt Hotels (NYSE:H) Given New $180.00 Price Target at SusquehannaMarketBeatNYSE:HRead Hyatt Hotels (NYSE:H) Given New $180.00 Price Target at Susquehanna2 hours agoVail Resorts (NYSE:MTN) Stock Picked Up by Analysts at LADENBURG THALM/SH SHMarketBeatNYSE:MTNRead Vail Resorts (NYSE:MTN) Stock Picked Up by Analysts at LADENBURG THALM/SH SH2 hours agoCoastalSouth Bancshares (NYSE:COSO) Stock Picked Up by Analysts at Brean CapitalMarketBeatNYSE:COSORead CoastalSouth Bancshares (NYSE:COSO) Stock Picked Up by Analysts at Brean Capital2 hours agoSpire Global (NYSE:SPIR) Upgraded at Alliance Global PartnersMarketBeatNYSE:SPIRRead Spire Global (NYSE:SPIR) Upgraded at Alliance Global Partners2 hours agoDWS Municipal Income Trust (NYSE:KTF) Stock Short Interest Report for SeptemberMarketBeatNYSE:KTFRead DWS Municipal Income Trust (NYSE:KTF) Stock Short Interest Report for September2 hours agoSiemens AG (OTCMKTS:SIEGY) Sees Large Growth in Short InterestMarketBeatOTCMKTS:SIEGYRead Siemens AG (OTCMKTS:SIEGY) Sees Large Growth in Short Interest2 hours agoQuantasing Group Ltd (NASDAQ:HERE) Sees Significant Growth in Short InterestMarketBeatNASDAQ:HERERead Quantasing Group Ltd (NASDAQ:HERE) Sees Significant Growth in Short Interest Featured Articles and OffersWant Private-Market Access to Kalshi and Polymarket? Try This ETFBy Jessica Mitacek | October 8, 2026Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)From InvestorPlace (Ad)3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a DipBy Dan Schmidt | October 11, 2026DraftKings Stacks the Deck: The $800M Prediction PivotBy Jeffrey Neal Johnson | October 7, 2026Salesforce Just Got a Rare Double Upgrade—What Changed?By Jeffrey Neal Johnson | October 12, 2026New Chip takes minutes, not daysFrom Eagle Publishing (Ad)Constellation Energy’s Google Deal Shows Why Nuclear Uprates Matter for AIBy Chris Markoch | October 6, 2026Skydance Just Became a Media Giant—With an $80 Billion Debt LoadBy Dan Schmidt | October 7, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 195 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
